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ABSTRACT

ASSESSMENT OF ATTENTION IN VASOPRESSIN-DEFICIENT
BRATTLEBORO RATS USING A FIVE-CHOICE SERIAL REACTION TIME
TASK
By
Michael D. Berquist II

Vasopressin is a neuropeptide that may influence behavioral and cognitive
processes. The Brattleboro rat is a mutant variation of the Long Evans strain that
exhibits no circulating vasopressin, resulting in a physiological state analogous to
diabetes insipidus. Behaviorally, Brattleboro rats exhibit diminished fear conditioning
and impairments in memory retention and sensory gating. The present study sought to
further evaluate the cognitive profile of rats with vasopressin deficiency by studying
attention in male and female Brattleboro rats, Long Evans rats, and heterozygous rats
using a five-choice serial reaction time task. Sessions to meet criteria were
significantly greater in the Brattleboro rats than Long Evans and heterozygotic rats;
and, males required significantly more sessions than Long Evans and heterozygotic
rats. Female Brattleboro rats displayed significantly poorer attention accuracy
compared to Long Evans and heterozygotic rats. Premature responses were
significantly greater in Brattleboro rats than Long Evans and heterozygotic rats.
Taken together, the present findings add to previous literature suggesting that
vasopressin deficiency diminishes cognitive functioning.
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INTRODUCTION

History of Vasopressin
In 1895, medical doctor George Oliver and physiologist Sir Edward Albert
Sharpey-Schäfer discovered that the administration of pituitary gland extracts would
produce hypertension in animal subjects. Shortly following this observation, Howell
(1898) concluded that the factor which exerted the pressor effects resided solely within
the posterior lobe of the pituitary gland. Moreover, it was not until the mid-20th century
that the two compounds of the posterior pituitary were identified as oxytocin and
vasopressin, along with their individual roles in peripheral, physiological processes.
Much of this work is credited to Du Vigneaud and his colleagues whom investigated the
synthesis and characterization of these physiologically-active substances (e.g., Du
Vigneaud, 1954-1955; Turner, Pierce, & Du Vigneaud, 1951; Katsoyannis & Du
Vigneaud, 1958). Due in part to these series of experiments, Du Vigneaud received the
Nobel Prize in chemistry in 1955. Since this seminal work by Du Vigneaud and his
colleagues, investigations into vasopressin effects have expanded from peripheral
functions towards central nervous system mediated effects— including cognitive and
behavioral domains. The present work focuses on the cognitive effects of vasopressin and
how these effects can be studied in the Brattleboro rat.
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Vasopressin
Properties
Arginine vasopressin (VP) is a neuropeptide/neurohormone consisting of nine
amino acids (CyS.-Tyr.Phe.Glu-NH2.Asp-NH2.CyS-Pro.Arg.Gly-NH2), which form into
a ring due to a disulfide bridge located between the two cysteine residues (e.g.,
Katsoyannis & Du Vigneaud, 1958; also see section in Caldwell, Lee, Macbeth, & Young
III, 2008 for review of VP structure). The VP gene is structurally-similar to the oxytocin
gene, but is oriented in the opposite transcriptional direction (Mohr, Schmitz, & Richter,
1988), and thus possesses biologically-distinct actions. Furthermore, the physiological
activities of VP are centered around different target sites within the body; in this
document, these sites will be referred to as “peripheral” (or outside of the central nervous
system) or “central” (or inside the central nervous system). The present introduction will
focus mainly on the contribution of VP in central processes.
VP is primarily synthesized in the magnocelluar cells of the hypothalamic
paraventricular (PVN) and supraoptic nuclei (SON) (Buijs, Swaab, Dogterom, & van
Leeuwen, 1978; Hou-Yu, Lamme, Zimmerman, & Silverman, 1986), and also within the
parvocellular cells of the aforesaid PVN (e.g., de Souza & Franci, 2010), and the
suprachiasmatic nucleus (SCN) (Sofroniew & Weindl, 1980; Buijs, van Eden,
Goncharuk, & Kalsbeek, 2003). Large axons of the VP cells within the PVN and SON
project to the posterior pituitary (e.g., see Brownstein, Russell, & Gainer, 1980) — where
VP, along with its carrier protein, (denoted neurophysin) (see Zimmerman & Robinson
1976 for further information on neurophysins), can be released into circulation in
2

response to various physiological stimuli. The two most common peripheral actions of
VP are: (1) to increase the reabsorption of water (hence VP is also called the “antidiuretic
hormone”) in the kidneys in response to osmotic stress (e.g., increased osmolality) (e.g.,
Dunn, Brennan, Nelson, & Robertson, 1973), and/or (2) VP can induce vasoconstriction
in blood vessels in response to alterations in hemodynamics (e.g., hemorrhage of blood
vessel) (e.g., Pittman, Lawrence, & McLean, 1982).
Receptors
Currently, three major receptor types of VP have been identified: argininevasopressin receptor 1a (Avpr1a or V1a), Avpr1b (V1b), and Avpr2 (V2); and all three
receptor isoforms are shown to be g-protein coupled (see Michell, Kirk, & Billah, 1979;
and Jard, Barberis, Audigier, & Tribollet, 1987 for review). Much progress has been
made in exploring the properties of these receptor isoforms and in assessing the
functional relevance of VP at these binding sites (e.g., see Barberis, Mouillac, &
Durroux, 1998 for review). For example, studies have demonstrated that the V2 receptor
isoform is responsible for mediating the antidiuretic properties in the kidneys (e.g., see
Jard, Barberis, Audigier, & Tribollet, 1987 for review). Additionally, high-dose
administration of VP to neonatal rats has been shown to disrupt adult kidney function
(Handelmann, Russell, Gainer, Zerbe, & Bayorh, 1983); indicating the important role of
VP in kidney diseases and normal physiological function. Further, following V2 receptor
activation, the associated intracellular transduction cascade has been shown to involve
coupling with adenylate cyclase (e.g., see Jard, 1983 for review). Identifying the
intracellular signal transduction cascades associated with these receptors can provide
3

important information not only about the immediate physiological effects following
receptor stimulation, but also about possible long-term, modulatory effects of various
biochemical agents such as VP.
Different from the transduction cascade pathways associated with kidney V2
receptors, V1 receptors located in vasculature (i.e., receptors coupled to smooth muscles)
(e.g., Nabika, Velletri, Lovenberg, & Beaven, 1985) and in the hepatocytes of the liver
(e.g., Cantau, Keppens, De Wulf, & Jard, 1980; Michell, Kirk, & Billah, 1979), have
been shown to be coupled with phospholipase; which initiates the phosphoinositol
pathway(s) to elevate intracellular Ca2+ concentrations (e.g., see Jard, Barberis, Audigier,
& Tribollet, 1987), among other intracellular processes. Furthermore, previous literature
suggests that the VP receptors in the brain predominantly consist of the V1 isoform (e.g.,
Kiraly, et al., 1986; Shewey & Dorsa, 1988). Thus, it is likely that central V1 receptors,
rather than V2 receptors, mediate the putative behavior and cognitive effects of VP.
Binding Sites and Distribution
In addition to the intracellular properties associated with the VP receptors,
numerous receptor binding sites have been identified in the brain. Many of these sites are
observed to exist in areas throughout the central nervous system, (away from the majority
of VP cell bodies found within the PVN, SON, and SCN), and within numerous
accessory nuclei. For example, Caffe and van Leeuwen (1983) found binding sites to
exist in the dorsomedial hypothalamus, the medial amygdala, and the locus coeruleus—
structures which are involved in a number of behavioral domains. Shortly following this
work, De Kloet, Rotteveel, Voorhuis, and Terlou (1985), found binding sites to exist
4

within such structures as the septum, central amygdala, dentate gyrus, olfactory nucleus,
and the nucleus tractus solitarii. With these findings taken together, VP has thus been
implicated in various domains affiliated with the aforementioned regions. Further, given
the large number of VP binding sites found within these accessory areas, other research
during this time began to identify numerous axonal projections of VP; which may offer
important information on the functional relevance of these associated binding sites.
Early microscopy work identified a number of VP projections within the brain—
some of which terminate at the binding sites noted previously. For example, Buijs (1980)
identified distinct vasopressinergic (VPergic) projections which extended from the
magnocellular nuclei of the PVN and/or SON, and/or from the parvocellular nuclei of the
SCN. Specifically, magnocellular VPergic projections were found to extend to the
amygdala, hippocampus, and spinal cord; and, parvocellular projections to the organum
vasculosum of the lamina terminalis, the lateral septum, and the lateral habenular nucleus
(Buijs, 1980). Additionally, during this time, Sofroniew (1980) using a
immunoperoxidase method, found magnocellular projections (i.e., PVN) to extend
towards the substantia nigra, the nucleus tractus solitarii, the nucleus commissuralis, and
to the spinal cord; and, parvocellular projections (i.e., SCN) to extend towards the
septum, thalamus, medial amygdala, ventral hippocampus, and a number of other regions
(for review on VPergic projections, see section in De Wied, Diamant, & Fodor, 1993).
Therefore, given the large number of VPergic projections found within the brain, it is
thus possible that the neuropeptide may also serve central, neurotransmitter-like roles
within the central nervous system which may ultimately modulate behavioral and/or
cognitive processes.
5

Vasopressin Extensions
Suprachiasmatic Nucleus
As mentioned previously, there are numerous projections of VP axons found
within the brain—many of which been shown to stem from the SCN and project to a host
of other target tissues (e.g., Buijs, 1980; Sofroniew, 1980). It has been known for some
time that the SCN, or the “master clock” of an organism, is largely responsible for the
circadian rhythmicity of a multitude of biochemical agents. The SCN performs this
rhythmic control through acting upon various cellular compartments located throughout
the body— such as along specific gene fragments within a cell’s nucleus. Moreover, VP
release has been shown to be entrained to such circadian rhythmicity with peak release
occurring during the subjective day phase—although VP release may vary between
species (Reppert Schwartz, Artman, & Fisher, 1983). Given this known relationship
between the SCN and release of VP, physiological actions associated with its rhythmic
release have also been found (e.g., see Buijs, van Eden, Goncharuk, & Kalsbeek, 2003,
for review on the SCN and associated biochemical components) . For example, the
circadian release of VP has been shown to exert a modulatory effect on the secretion of
corticotrophin releasing factor (CRF) and adrenocorticotropic hormone (ACTH) (e.g.,
Raymond, Leung, Veilleux, & Labrie, 1985)—two compounds which are in part
responsible for the excessive cortisol release during periods of chronic stress (e.g.,
Aguilera, 1994; Volpi, Rabadan-Diehl, & Aguilera, 2006). Furthermore, research has
suggested that VP may function to amplify the excitatory effect produced by the SCN
(Ingram, Snowball, & Mihai, 1996). With these findings taken together, the relationship
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between VP and the SCN has stimulated research which further explores the utilization of
the neuropeptide within circadian domains.
Social Behaviors
There are several areas of social behavior that may be modulated by the effects of
VP. One such research area that has received much attention has been aggression.
Aggressive behavior, for instance, has been shown to increase following microinjections
of VP into the anterior hypothalamus of Golden hamsters (Ferris et al., 1997). Moreover,
a direct relationship has been suggested to exist between the V1 a receptor isoform and
aggression as studied in Syrian hamsters— with a higher V1a receptor distribution in the
anterior hypothalamus equated to increased observed aggression (Albers, Dean, Karom,
Smith, & Huhman, 2006). Accompanying the V1a receptor studies which associate the
receptor isoform with aggression, additional research has shown that mice lacking the
V1b isoform, display reduced aggression, and alterations in social recognition as well
(Wersinger, Ginns, O’Carroll, Lolait, & Young III, 2002). Based on these studies, VP
may serve a modulatory role in aggressive behaviors and further research is thus
necessary to elucidate the biochemical actions VP places within specific areas of the
brain affecting such behavioral responses.
Other aspects of social behavior, such as pair-bonding and social recognition,
have been examined as well. Perhaps among the most robust observations involving VP
and social behaviors, has been through the examination of VP receptor distributions in
the ventral pallidum that exist between different species of voles (see, Donaldson, &
Young, 2008 for review). For example, a causal relationship has been shown to exist
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between the high-VP receptor distribution located within the ventral pallidum of the
prairie vole—which results in a monogamous behavioral phenotype— and, with the lowVP receptor distribution within the ventral pallidum of the nonmonagamous meadow
vole (Donaldson & Young, 2008). Furthermore, by using a viral-vector method of
transferring genes, previous studies have found that if the VP gene is taken from the
monogamous prairie vole, and transferred to the nonmonagamous meadow vole, the
meadow vole will then adopt the social behavior of the prairie vole (Donaldson & Young,
2008). Therefore, it seems that that the distribution levels of VP are largely responsible
for inducing a specific behavioral phenotype within the vole species.
In addition to the aforementioned vole studies, the importance of VP and social
behaviors has been suggested to be more relevant to males than females— as females do
not appear to rely on VP for social recognition as much as males (Bluthe & Dantzer,
1990; Bielsky, Hu, & Young, 2005). Despite this robust observation, research using
rodents has found relationships between VP neurotransmission and social behaviors. For
instance, Engelmann, Ludwig, and Landgraf (1994), using a microdialysis procedure,
found that following stimulation to the SON, a significant correlation existed between
endogenous VP release in the SON and septum, and increased social memory
(recognition) performance in male rats. Additionally, this improvement could be
partially blocked by a V1 receptor antagonist (Engelmann, Ludwig, & Landgraf, 1994).
This association found between VP release and social memory would be further
delineated with successive research using transgenic mice models. Current research has
found that severe impairments in social recognition have been shown to exist in V1 a
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knockout mice compared to wildtype controls (Bielsky, Hu, Szegda, Westphal, & Young,
2004; Egashira et al., 2007); and mild impairments in social recognition to exist in V1 b
knockout mice (Wersinger, Ginns, O’Carroll, Lolait, & Young III, 2002). Furthermore,
by re-expressing the V1a gene in the lateral septum of V1a knockout mice, deficits in
social recognition became completely restored (Bielsky, Hu, Ren, Terwilliger, & Young,
2005). These findings suggest that the V1a receptor in the lateral septum is necessary for
normal social recognition function (at least in male rodents; see above). Taken together,
these data suggest the relevance of VP in modulating social behaviors.
Stress, Depression, and Anxiety
VP has been previously demonstrated to have fibers projecting to the zona externa
of the median eminence (e.g., Antunes, Carmel, & Zimmerman, 1977), and thus to the
anterior pituitary (via a blood portal system). Given the terminating sites of these VPergic
projections to the median eminence, it has been postulated that VP may affect the
pituitary-adrenal-axis (e.g., Antunes, Carmel, & Zimmerman, 1977). It was later found
that stress-responsive components, such as CRF (also referred to as “corticotropic
hormone”), and ACTH, are physiologically-involved with the hypothalamic-pituitaryaxis (HPA) (referring to the anterior pituitary) (e.g., Rivier & Vale, 1983; Aguilera, 1994;
Volpi, Rabadan-Diehl, & Aguilera, 2006). Moreover, as mentioned above, VP has been
shown to exert a modulatory role on the release of HPA-affiliated stress-response factors,
such as CRF and ACTH (e.g., Rivier & Vale, 1983; Aguilera, 1994); and additionally,
cell bodies of AVP and CRF have been found to co-localize in the external region of the
median eminence (e.g., Whitnall, Smyth, & Gainer, 1987). These findings strongly
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support a physiological relationship to exist directly between VP and the factors (e.g.,
CRF, ACTH, cortisol, etc.) included in mediating the effects of chronic stress.
Furthermore, behavioral studies have provided additional evidence supporting the impact
of VP in the stress response. For example, rats put into a 10-minute forced swim session
were shown to have elevated levels of VP release in both the SON and PVN (Wotjak et
al., 1998; and for review on VP and stress, see section in Caldwell, Lee, Macbeth, &
Young III, 2008).
Accompanying the direct association between VP, CRF, ACTH, and the anterior
pituitary, physiological interactions have been found between the V1b receptor isoform
and the adrenal glucocorticoids. For example, recent evidence shows that V1b receptor
up-regulation or down-regulation will occur depending upon circulating levels of
glucocorticoids (Aguilera & Rabadan-Diehl, 2000). The release of glucocorticoids is
directly proportionate to signals coming from the HPA, and once in circulation and thus
reaching the brain, glucocorticoids exert numerous effects on functional
neurochemistry—many effects which are strongly associated to stress, anxiety, and
depression (for review, see Nestler et al., 2002). Moreover, elevated levels of VP have
been found in the plasma of depressed patients compared to healthy controls (van Londen
et al., 1997); and treatments for depression, such as the selective-serotonin reuptake
inhibitor Fluoxetine, has been shown to increase VP afferent development in select brain
regions (Ricci & Melloni Jr., 2012). These findings taken together suggest that VP shares
a relationship with the mechanisms associated with depression, and thus may serve a
useful role for therapeutic intervention.
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In addition to the role of VP in the induction of stress and depression, the V1a
receptor has received support for influencing anxiety-related measures as well. For
example, V1a receptor knockout mice have been shown to exhibit reduced anxiety-like
behavior in an elevated plus maze (Egashira et al., 2007); and, pharmacologically, V1
receptor antisense administration has been shown to reduce anxiety-related behavior in
rats (Landgraf et al., 1995). Moreover, given the extensive literature supporting the role
of VP in stress, depression, anxiety, and the structures affiliated with these ailments—
which also contain VPergic projections, such as the amygdala (e.g., Willcox, Poulin,
Veale & Pittman, 1992; Dorsa, Petracca, Baskin, & Cornett, 1984), and the hippocampus
(Zhang & Hernandez, 2013)— VP has thus received much attention which attempts to
delineate its functional relevance in these pathologies (for review see Scott & Dinan,
1998; De Wied & Sigling, 2002; Neumann & Landgraf, 2012).
Brattleboro Rats
History
The Brattleboro rat was discovered as a useful model for studying possible
relationships between VP and associated behaviors. The strain was identified during the
1960’s in Brattleboro, Vermont. Dr. Henry Schroeder and his associate Mr. Tim Vinton
noticed that some of the rat pups in their breeding colony were drinking excessive
amounts of water, and with the administration of VP, this behavior could be corrected
(Valtin, 1982; Mohring et al., 1978). After isolating these rats and reporting the behavior
to several enthused colleagues, the Brattleboro rats as the “water-consumers” came to be
called, became a successfully-bred, naturally occurring mutant rat strain to investigate
11

experimentally (Valtin, 1982). Moreover, the Brattleboro rats displayed polydipsic
behavior (excessive water consumption) and polyuria (excessive urination), and therefore
have been considered to be an animal model of congenital diabetes insipidus.
Genetics and Characteristics
It was later determined that the cause of the Brattleboro rats’ excessive water
consumption was due to a single guanisine residue deletion in the second exon of the
arginine VP gene (Schmale & Richter, 1984). This deletion results in impaired secretion
of the neuropeptide, which results in no circulating VP found in the animal (Schmale,
Ivell, Brendl, Darmer, & Richter, 1984; Majzoub, Carrazana, Shulman, Baker, &
Emanuel, 1987; Grant, 2000). Further, several alterations have been found in the
Brattleboro rats in various hormonal factors (for review, see Sokol & Zimmerman, 1982)
and neurotransmitter concentrations (Dawson, Wallace, King, 1990; Feenstra,
Snijdewint, Van Galen, & Boer, 1990). Extensions of these alterations into various
domains will be discussed later in this document.
In addition to the excessive drinking behavior found in the Brattleboro rats, body
growth (measured in body weight), tail length and posterior pituitary gland weight were
also found to be underdeveloped compared to wildtype controls (Arimura, Sawano,
Redding, & Schally, 1968). Upon further examination, Arimura, Sawano, Redding, and
Schally (1968) also found that growth hormone content in the posterior pituitary of
Brattleboro rats was significantly lower than what was found in controls; however,
growth-hormone releasing factor (the chief regulatory factor responsible for the synthesis
and excretion of growth hormone) was not found to be different. This suggests that other
12

compounds beyond growth-hormone releasing factor may be responsible for the impaired
somatic development observed in the Brattleboro rats (Arimura, Sawano, Redding, &
Schally, 1968).
Along with the previously mentioned deficiencies in somatic development and
concentrations of growth hormone found with the Brattleboro rats, the strain has also
been shown to have smaller brains (4-9% smaller) compared to heterozygous controls
(Boer, Van Rheenen-Verberg, & Uylings, 1982). Additionally, diminished proliferative
growth of the cerebellum and medulla oblongata were also found in both male and female
Brattleboro rats (Boer, Van Rheenen-Verberg, & Uylings, 1982). Accompanying these
structural underdevelopments, numerous molecular components were found to be
reduced as well—specifically, DNA content in the forebrain, cerebellum, and olfactory
bulbs were found to be lower in Brattleboro rats compared to heterozygotic controls
(Boer & Patel, 1983). Furthermore, expressed differences in monaminergic agents—
including elevated levels of dopamine, serotonin, noradrenaline/norepinephrine,
glutamine, and taurine in select brain regions—have been observed to exist in the
Brattleboro rats versus wildtype controls (Dawson, Wallace, & King, 1990; Feenstra,
Snijedwint, Galen, & Boer, 1990). These differences may exist due to the putative role of
VP as a key neuropeptide which interacts with various factors in neurodevelopment (see
Boer et al., 1980; and Ugrumov, 2002, for review on VP and neurodevelopment); such as
modulating the noradrenaline neurotransmission pathways (e.g., Boer, Feenstra,
Botterblom, Korse, & Te Riele; 1995).

13

Behavioral Studies
One of the first extensions of VP into the domain of mental processing came
through the work of De Wied and colleagues during the mid-1900’s. For instance, in a
shuttlebox conditioned avoidance response paradigm—which can be suggested to
measure contexutal memory (i.e., pairing an environment with a specific stimulus such as
a shock) — it was found that animals with ablations to the posterior and intermediate
lobes of the pituitary gland displayed impairments in the maintenance of an avoidance
response (De Wied, 1965). Moreover, multiple doses and varied administration intervals
of VP analogues were assessed in rats, and found to augment memory retention in active
and passive avoidance tasks in a time-dependent manner (Bohus, Ader, & DeWied,
1972). This preliminary research stimulated the hypothesis that VP may subserve some
modulatory role in memory processes.
Also during this time, the Brattleboro rats were becoming a model employed to
investigate the effects of VP deficiency (see Valtin, 1982). Ostensibly due to the
emergence and utilization of this mutant rat for research purposes, De Wied and
colleagues were able to investigate the strain in several animal-memory paradigms. For
example, it was noted that the Brattleboro strain exhibited deficits in learning, compared
to heterozygotic rats with partial VP deficiency, using a one-trial step-through passive
avoidance test (De Wied, Bohus, & van Wimersma Greidanus, 1975). Additionally,
following administration of desglycinamide-8-lysine, a VP analogue, these deficits were
ameliorated (De Wied, Bohus, & van Wimersma Greidanus, 1975).
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The relationship between VP and shuttlebox behavior were expanded upon in
Bohus, van Wimersma Greidanus, and De Wied (1975) where the Brattleboro rats were
found to have deficits in acquisition of avoidance, extinction of behavior in pole jumping
avoidance, and in the retention of passive avoidance response. In response to these
findings and the conclusions made therein about the Brattleboro strain, other researchers
such as Brito, Thomas, Gingold, and Gash (1980), sought to delineate other types of
memory (e.g., reference-memory) that may be impaired in this strain and suggested that
the Brattleboro rats exhibit deficits in reference-memory, and perhaps mild impairments
in working-memory. Additionally, subsequent pharmacologic studies were also providing
evidence supporting the role of VP in memory as well. For example, Strupp and
colleagues (1990) noted that the administration of a VP metabolite was shown to improve
memory retrieval in a rat social interaction, appetitive-motivated paradigm. These studies
would provide assessments of memory performance in the Brattleboro rats, and further
support the role of VP within this cognitive domain.
Conflicting with these findings in the shuttlebox behavior, Brito, Thomas, Gash,
and Kitchen (1982) were not able to replicate these results; rather, there were no
differences found between Brattleboro rats and controls in shuttlebox/shock-motivated
assessments (i.e., approach-avoidance conflict, passive avoidance), in performance in a
working memory task (alternating T-maze), in visual and olfactory discrimination
(reference memory), and in a species-specific behavioral response (i.e., burying an
aversive stimulus as a defensive response (see Pinel & Treit, 1978 for further information
of this behavior)). Moreover, the researchers concluded that the Brattleboro rats exhibited
differences in temperament (using measures of neophobia, timidity, etc.) which may
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conflict with performance in these cognitive-behavioral tasks (Brito, Thomas, Gash, &
Kitchen, 1982). This conclusion provides a relevant point to consider when speculating
about Brattleboro rats’ performance in cognitive-behavioral tasks, and will be considered
later in this document. In addition, to add further robustness to experiments, researchers
have incorporated rats with partial VP deficiency as well. For example, Aarde and
Jentsch (2006) found delay-dependent deficits in choice accuracy in heterozygote rats
(with partial deficiency in VP) compared to wildtype Long-Evans controls, using a
delayed-non-to-match position paradigm— a model suggested to measure spatial
working memory. These memory studies taken together add supporting evidence for a
central, modulatory role of VP in cognitive domains, though conclusions about how VP
exerts these effects differentially across paradigms remain unclear.
As mentioned previously, the Brattleboro rats have been suggested to exhibit
different emotional profiles than other strains. To test this hypothesis, researchers
examined the Brattleboro rats using animal measures of emotionality—one such measure
is the freezing response. For example, one study found attenuated freezing responses in
Brattleboro rats using a conditioned freezing paradigm (Stoehr, Cheng, & North, 1993).
As a follow-up to this finding, similar attenuated freezing responses were found in
normal rats following V1 antagonism administration (Stoehr, Cheng, Serlin, Cramer, &
North, 1993). Taken together, these studies lend support to the notion that the Brattleboro
rats display an altered emotional response. Moreover, these results also suggest that VP
plays a role the retention of this behavior— as the study using pharmacologic
manipulation of VP indicated. Further, Colombo, Hansen, Hoffman, and Grant (1992)
found that rats (the M520 strain) carrying the diabetes inspidus gene, expressed different
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levels of timidity (measured by adaptability in a novel environment) in a t-maze
paradigm, than what was found in Brito, Thomas, Gash, and Kitchen (1982); suggesting
that the DI gene itself may not be responsible for the altered timidity found within the
Brattleboro strain. Clearly, more research is necessary that evaluates the differences
between the parameters set within these paradigms, and for potential differences in
Brattleboro rats from different breeders—as rats from different colonies may display
different behavioral and emotional profiles (e.g., noted in Laycock, Gartside, &
Chapman, 1983; also see, Herman, Thomas, Laycock, Gartside, & Gash, 1986).
In addition to the shock-avoidance studies mentioned above, recent research has
provided suggestions about the effects of maternal genotype on Brattleboro rats’ stress
response function and development (e.g., Zelena, Mergl, & Makara, 2009); adding
further complexity to exploring the emotional profile of the Brattleboro strain. Further,
Brattleboro rats have been shown to exhibit attenuated depression-like behavior in a
forced swimming test (Mlynarik, Zelena, Bagdy, Makara, & Jezova, 2007), and
prolonged elevation of plasma corticosterone and oxytocin levels following a 10-minute
forced swim stressor (Zelena et al., 2009). Taken together, these findings suggest that the
Brattleboro rats exhibit irregularities in stress-response activity; however, further research
is necessary to delineate the neurophysiological causes of these irregularities, and to what
impact they may have on performance in cognitive-behavioral tasks.
Along with previous studies indicating that the Brattleboro display altered stress
responses compared to controls using a forced-swim stressor (Mlynarik, Zelena, Bagdy,
Makara, & Jezova, 2007; Zelena et al., 2009), and deficits in assessments of memory
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(Stoehr, Cheng, & North, 1993; Bohus, van Wimersma Greidanus, & De Wied, 1975; De
Wied, Bohus, van Wimersma Greidanus, 1975), the strain has been found to exhibit
alterations in other cognitive domains as well. For example, innate social recognition
deficits in the Brattleboro strain have also been ameliorated following administration of
synthetic arginine VP into the septum of the rats, and similar deficits can be induced in
Long Evans rats following V1 antagonist administration into the same brain region
(Engelmann & Landgraf, 1994). One other area of cognition examined in the Brattleboro
strain, has been attention. Recently, the Brattleboro strain has been found to exhibit
deficits in pre-pulse inhibition (e.g., Feifel & Priebe, 2001)—which is suggested to
measure a pre-attention process referred to as “sensorimotor gating.” Moreover, this
finding has also been found in female Brattleboro rats (Feifel, Shilling, & Melendez,
2010); which, suggests the effects are due to some quality of the Brattleboro strain rather
than a sexually-dimorphic characteristic. Moreover, the deficits are ameliorated in both
sexes of the Brattleboro strain following antipsychotic administration (Feifel, Shilling, &
Melendez, 2010) and novel experimental antipsychotic administration in male rats
(Feifel, Melendez, Priebe, & Shilling, 2007). The implications of these findings will be
discussed later in this document.
As mentioned previously, deficits in sensorimotor gating were observed in the
Brattleboro rats; which suggest that the absence of VP could potentially modulate aspects
of attention as well. Moreover, Jentsch, Arguello, and Anzivino (2003) found that
Brattleboro rats displayed deficits in attentional engagement using a lateralized reaction
time task. Briefly, this study required animals to correctly respond to visual stimuli via
nose pokes in two apertures that randomly presented flashes of visual stimuli. Trials were
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initiated via nose poke into a central aperture. Following this response, a visual stimulus
was presented randomly in one of two apertures located on either side of the central
aperture. Measures of accuracy, response times, premature responses, omissions,
incorrect responses, and reinforcement retrieval times were collected (Jentsch, Arguello,
& Anzivino, 2003). Furthermore, Jentsch (2003) found superior performance in a
lateralized reaction time task using rats with partial VP-deficiency; which, overall, these
studies suggest that VPergic tone may exert some effects on attention performance within
the parameters of the lateralized reaction time task. Amid these prior studies using the
lateralized reaction time task, further evaluations assessing the Brattleboro rats, VP, and
attention must be examined. Therefore, further research is necessary to measure other
aspects of attention and motivation not assessed in the lateralized reaction time task.
The Five-Choice Serial Reaction Time Task
The operant five-choice serial reaction time task (5-CSRTT) has been commonly
used to assess attention since the 1970’s (for review, see Robbins, 2002). This method of
assessing attention in animal models is more common than the aforementioned lateralized
reaction time task and differs from the paradigm in several ways. Briefly, the 5-CSRTT
requires animals to visually detect a stimulus light presented randomly in one of five
apertures within a fixed-time period. The animals initiate the task by emitting a response
on a stimulus (e.g., pressing a lever) within the chamber. This response then results in the
appearance of the visual stimulus to occur randomly in one of five apertures and within a
fixed-time period. Subjects must then nose-poke the illuminated hole within a fixed-time
period in order to receive reinforcement, and initiate another trial. Failures to make a
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nose-poke response (omission), a response before the onset of the visual stimulus
(premature response), or a response into an incorrect aperture following visual stimulus
presentation (incorrect response), results in a time-out period (e.g., typically a fivesecond period where the houselight is extinguished and response on the stimulus that
typically initiates a trial has no outcome).
To vary the parameters associated with the 5-CSRTT, higher attentional demands
can be placed on the subjects by altering the visual stimulus duration (e.g., changing the
stimulus duration from 1.0 sec to 0.1 sec), and through varying the inter-trial interval
(ITI) (i.e., instead of the visual stimulus appearing 5.0 seconds following head entry, have
it randomized to appear 1.0, 5.0, and 10.0 seconds following entry). Additionally,
distractors, such as bursts of white noise, can also be incorporated into the 5-CSRTT
paradigm to add further attentional demands on the subjects.
The 5-CSRTT is regarded as an assessment of attention accuracy— including
spatial attention, attention shifting, and inhibitory control— as well as other variables
such as motivation, impulsivity, compulsivity, and cognitive flexibility (e.g., Robbins,
2002; Chudasama & Robbins, 2004;Amitai & Markou, 2010). These characteristics
make the 5-CSRTT a robust animal model for evaluating multiple facets of behavior and
mental processing. Moreover, although similar to the lateralized reaction time task in
some ways, the 5-CSRTT may add further attentional engagement due to 1) an increase
in task difficulty and 2) requiring the animal to shift attention from a stimulus that
initiates a trial to a second stimulus located elsewhere in the experimental chamber (See
Appendix A for photograph of chamber). Therefore, the 5-CSRTT adds additional
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measurements of attention not addressed by the lateralized reaction time task, and may
thus reveal relevant relationships between VP and attention.
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RATIONALE

Vasopressin has been implicated within various behavioral and cognitive
domains, such as memory, social behaviors, and mental disorders, and is thus a relevant
compound to consider for experimental examination. One of the challenges associated
with experimental analyses is identifying a potential animal model which has high
construct validity. The Brattleboro rat strain is uniquely relevant to addressing this
challenge by possessing a genetic condition which completely impairs the animal’s
ability to synthesize vasopressin. Moreover, recent evidence has suggested that the
Brattleboro rats exhibited deficits in such areas as memory (e.g., Stoehr, Cheng, & North,
1993), attentional engagement (Jentsch, Arguello, & Anzivino, 2003), sensorimotor
gating (e.g., Feifel, Shilling, & Melendez, 2010), and social discrimination (Feifel et al.,
2009). These findings provide further support for incorporating the Brattleboro strain in
models that may address deficits associated with human mental disorders.

To date, no previous study has evaluated the Brattleboro rats in the five-choice
serial reaction time task—a well-validated assessment of attention. Additionally,
experimental studies are lacking that include female Brattleboro rats into their analyses,
so much of the knowledge about potential sex differences within this strain are largely
unknown. Therefore, the present study sought to assess attention performance in
vasopressin-deficient rats by studying homozygous Brattleboro rats, heterozygous
Brattleboro rats derived from breeding Long Evans and Brattleboro rats, and wildtype
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Long Evans rats using a 5-CSRTT paradigm. Experiments also included both male and
female rats to evaluate potential sexually-dimorphic effects of vasopressin deficiency.
These findings expand upon the neurocognitive profile of the Brattleboro rats and suggest
that levels of circulating vasopressin may influence aspects of attention, depending on
sex. The goal of this study was to evaluate both male and female Brattleboro rats in a
common animal model of attention, the five-choice serial reaction time task. This
research further supports the utilization of the Brattleboro rat within cognitive and
behavioral tasks that may ultimately provide support for modeling human disorders.
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METHODS

Subjects
Male and female Brattleboro (BRAT) rats (N=10 and N=8, respectively) and
heterozygotes (HZ) rats (N=10 and N=10) were obtained from a breeding colony at
University of California, San Diego (San Diego, CA, USA), while male and female Long
Evans rats (N=10 and N=10) were obtained from Charles River Laboratories (Portage,
MI, USA). Animals were housed in a temperature and humidity-controlled vivarium
kept on a 12 hour light-dark cycle with free access to water in their home cages. Food
was restricted to a single daily feeding in order to maintain 85% of free-feed body
weights. Rats were group housed within strain and sex, with the exception of male
Brattleboro rats, which had to be separated due to aggressive behavior. Following
training sessions, rats were individually housed for 30 min to provide a feeding period.
Supplemental food pellets were subsequently provided in their homecages upon returning
to group housing. All procedures were consistent with the Guide for the Care and Use of
Laboratory Animals (2011) and were approved by the Institutional Animal Care and Use
Committee at Northern Michigan University. Experimental sessions were conducted five
days per week.
Apparatus
These procedures used eight rat operant chambers contained in sound-attenuating
cabinets equipped with fans for ventilation and masking noise (Med-Associates, St.
Albans, VT, USA). Each chamber was equipped with a single retractable lever positioned
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on the center of one wall, directly below the food pellet dispenser that delivered 45 mg
dustless food pellets (BioServ, Frenchtown, NJ, USA). This wall also contained a
houselight and receptacle for a 100ml water bottle, both located near the ceiling. The
opposite wall contained five equally-spaced apertures equipped with stimulus lights and
photo beam sensors. All experimental events and data collection was conducted using
Med-PC version IV software (Med-Associates).
Training procedures
Prior to 5-CSRTT training, a 45 min acclimation session was conducted by
placing rats in the experimental chambers with only the house light activated and the
food-pellet dispenser set to fixed time 60 sec schedule. This session was included to
habituate the animals to the experimental chambers and to the location and the sound of
the food magazine. All animals moved onto training following this habituation session.
Training for the 5-CSRTT was conducted in five phases, and all training sessions
ended after 100 trials or 30 min, whichever came first. During the first phase, all
stimulus lights were activated and a nose-poke into any of the apertures resulted in the
delivery of a food-pellet reinforcer. A nose-poke also deactivated all stimulus lights for a
5 sec period. First-phase training sessions were 30 min in length and the training criteria
consisted of a rat evoking at least 10 nose-pokes for 1 session. This first phase aimed to
train the animals to establish the nose-poke contingency.
During the second phase of training, rats were required to press the center lever
in order to activate the five stimulus lights. A subsequent nose-poke into any aperture led
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to the deactivation of the stimulus lights and the delivery of a food pellet. Rats moved on
to the third phase of training after achieving at least 10 food pellets within a single
session.
Phase three training procedures were similar to phase two except that a lever press
led to the activation of only one stimulus light, which was selected randomly 5 sec later.
Only a nose-poke into signaled aperture led to the delivery of a food-pellet, whereas no
experimental event occurred after a nose-poke into a non-signaled aperture. However,
failing to emit a nose-poke into the lit aperture within 5 sec (an “omission”) led to
deactivating the stimulus light and the houselight for a 5 sec period. After the timeout
period ended, another lever press was necessary to activate a stimulus light. The goal of
establishing this contingency was to train the rats of a temporal consequence following
the absence of a response. In order to proceed to phase four, rats were required to omit no
more than 10 percent of total trials for 2 out of 3 consecutive sessions.
Phase four was identical to phase 3 except that a nose-poke occurring during the 5
sec after the lever press, but before the activation of a stimulus light (a “premature
response”), led to a timeout. This training phase introduced the animals to another
condition (in addition to an omission) that would result in a timeout period. The goal of
this phase was to minimize both premature and omission values during a training session.
As such, the criterion for proceeding to the final phase of 5-CSRTT training was 2 out of
3 consecutive trials where omissions and premature values were no more than 10 percent
of total trials initiated.
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The final phase of 5-CSRTT training was identical to the fourth phase of training
except that stimulus was shortened to 0.5 sec and nose-pokes occurring in the signaled
aperture within 5 sec led to a food-pellet delivery. Moreover, incorrect responses led to a
timeout. If the animal made a nosepoke in the correct aperture, a food pellet was
immediately delivered. Training continued until correct choice accuracy had stabilized;
which was defined as no more than 10% variation in correct choice accuracy with
omitting no more than 20% total trials initiated for 6 out of 8 consecutive sessions. Once
choice accuracy had stabilized for an individual rat, that rat was considered to have
completed the 5-CSRTT training. (See Appendix B for box diagram detailing the
procedure of the final 5-CSRTT training phase).
Bodyweight and water intake
Immediately following completion of 5-CSRTT training, all rats were free-fed for
bodyweight and water consumption analysis. In addition to the homecage water
consumption assessment, the free-fed rats were put into the experimental chambers
supplied with a water bottle to assess water consumption for a 60 min period. The doors
on the experimental chambers were left open during this session. Two measures were
recorded during this 60-minute session: 1) the amount of water consumed from the 100ml
bottle placed in the experimental chamber, and 2) the amount of licks made to the water
bottle.
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Data Analysis

The following dependent variables were measured for 5-CSRTT performance:
percent accuracy, trial omissions, and premature responses. Data were reported as means
(+/- the standard error of the mean [SEM]). Percent accuracy was calculated by dividing
the number of correct responses by the sum of correct and incorrect responses, and then
multiplying this value by 100. Each rat’s stable percent accuracy value was reported as
the mean percent accuracy across the 8 sessions where training criteria were met for the
final phase of 5-CSRTT training. Means for premature responses and omissions were
calculated in the same manner. All 5-CSRTT dependent variables were analyzed using a
one-way between groups analysis of variance (ANOVA). Statistically significant
differences were further assessed using the Unprotected Fisher’s Least Significant
Difference (LSD) multiple comparisons test. A chi-square analysis was conducted to
assess differences in the number of rats meeting the final-phase training criteria between
strains. A one-way ANOVA was conducted to assess differences in free-feed
bodyweights, 24 hour homecage water consumption, or experimental dependent variables
between strains in male or female rats during the 60-minute session. Again, statistically
significant differences were further assessed using the Unprotected Fisher’s LSD multiple
comparisons test.
Given that sample sizes were reduced due to some rats failing to meet the training
criteria, which subsequently reduced power, one-way between groups ANOVAs were
also conducted in order to provide an assessment of strains between samples containing
both male and female rats. Statistically significant differences were further assessed
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using Unprotected Fisher’s LSD comparisons tests. All analyses were conducted using
GraphPad Prism for Windows version 6 (GraphPad Software, La Jolla, CA, USA).
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RESULTS

Sessions to training criteria
Rats were determined to have failed to learn the task if they exceeded the number
of sessions to meet a phase by over two standard deviations, compared to the mean
number of sessions met by the other rats of the same strain and sex. In addition, one LE
male rat died prior to the final 5-CSRTT phase. The number of rats completing the final
5CSRTT training criteria consisted of the following: male Long Evans (LE) (6 out of the
original 10), female LE (9/10); male heterozygotes (HZ) (9/10), female HZ (6/10); and
male Brattleboro rats (BRAT) (6/10), female BRAT (5/8). As mentioned previously,
given the relatively low samples sizes reached for many of the groups, a one-way
between groups ANOVA was conducted to assess differences between strains in groups
containing both male and female rats.
Figure 1 presents the number of male rats that completed all training. No
statistically-significant differences were found in the number of males rats per strain that
completed the training χ2(2, N=29) = 2.468, p > 0.05.
Figure 2 presents the number of female rats that completed all training. No
statistically-significant differences were found in the number of female rats per strain that
completed the training χ 2(2, N=28) = 2.643, p > 0.05.
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Figure 3 presents the number of male and female rats that completed all training.
No statistically-significant differences were found in the number of male and female rats
per strain that completed training χ 2(2, N=57) = 0.449, p > 0.05.
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Figure 1 shows the number of animals as a function of status (pass or fail)
and strain (LE, HZ, or BRAT) in the male rats completing the 5-CSRTT
training.
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Figure 2 shows the number of animals as a function of status (pass or fail)
and strain (LE, HZ, or BRAT) in the female rats completing the 5-CSRTT
training.
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Figure 3 shows the number of animals as a function of status (pass or fail)
and strain (LE, HZ, or BRAT) in the male and female rats completing the
5-CSRTT training.
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Figure 4 presents the mean number of sessions to meet criteria for the male rats
Statistically significant effects were found in males, F(2,18) = 4.022, p < 0.05, which
were due to BRAT rats requiring significantly more sessions to meet the training criteria
than LE and HZ rats. No statistically significant effects were found between LE and HZ
rats.
Figure 5 presents the mean number of sessions to meet criteria for the female rats.
No statistically-significant differences were found in female rats F(2, 17) = 0.3587, p >
0.05.
Figure 6 presents the mean number of sessions to meet criteria for the male and
female rats. Statistically-significant differences in the number of sessions to meet the
training criteria were observed between strains for male and female rats F(2,38) = 3.339,
p < 0.05, which were due to BRAT rats requiring significantly more sessions to meet the
training criteria than LE and HZ rats. No statistically significant effects were found
between LE and HZ rats.
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Figure 4 shows the mean number of sessions as a function of strain
(LE, HZ, or BRAT) in the male rats, *p < 0.05 versus LE, +p <
0.05 versus HZ.
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Figure 5 shows the mean number of sessions as a function of strain
(LE, HZ, or BRAT) in the female rats.
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Figure 6 shows the mean number of sessions as a function of strain
(LE, HZ, or BRAT) in the male and female rats, *p < 0.05 versus
LE, +p < 0.05 versus HZ.
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Percent accuracy
Figure 7 presents percent accuracy data during the sessions where training criteria
were met for male rats. Percent accuracy for the male rats did not differ significantly
F(2,18) = 0.0629, p > 0.05
Figure 8 presents percent accuracy data during the sessions where training criteria
were met for female rats. Statistically-significant differences were observed between
strains in female rats F(2,17) = 4.330, p < 0.05, which was due to female BRAT rats
exhibiting significantly poorer accuracy than LE and HZ rats. No statistically significant
effects were found between LE and HZ rats.
Figure 9 presents percent accuracy data during the sessions where training criteria
were met for male and female rats. No statistically-significant differences were observed
between strains in male and female rats F(2,38) = 0.9221, p > 0.05.
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Figure 7 shows the percent accuracy as a function of strain (LE, HZ, or
BRAT) in the male rats.
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Figure 8 shows the percent accuracy as a function of strain (LE,
HZ, or BRAT) in the female rats, *p < 0.05 versus LE, +p < 0.05
versus HZ.
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Figure 9 shows the percent accuracy as a function of strain (LE,
HZ, or BRAT) in male and female rats.
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Premature responses
Figure 10 presents the mean number of premature responses exhibited during the
sessions where training criteria were met for male rats. No statistically-significant
differences were observed between strains in male rats F(2,18) = 1.986, p > 0.05.
Figure 11 presents the mean number of premature responses exhibited during the
sessions where training criteria were met for female rats. No statistically-significant
differences were observed between strains in female rats F(2,17) = 3.051, p > 0.05.
Figure 12 presents the mean number of premature responses exhibited during the
sessions where training criteria were met for male and female rats. Statisticallysignificant differences were observed between strains F(2,38) = 4.865, p < 0.05, which
was due to BRAT rats exhibiting more premature responses than LE and HZ rats. No
statistically significant differences were found between LE and HZ rats.
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Figure 10 shows premature responses as a function of strain (LE, HZ, or
BRAT) in male rats.
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Figure 11 shows premature responses as a function of strain (LE,
HZ, or BRAT) in female rats.
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Figure 12 shows premature responses as a function of strain (LE,
HZ, or BRAT) in male and female rats, *p < 0.05 versus LE, ++p
< 0.01 versus HZ.
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Omissions
Figure 13 presents the mean number of omissions exhibited during the sessions
where training criteria were met for male rats. No statistically-significant differences
were observed between strains in male rats F(2,18) = 0.4552, p > 0.05.
Figure 14 presents the mean number of omissions exhibited during the sessions
where training criteria were met for female rats. No statistically-significant differences
were observed between strains in female rats F(2,17) = 0.5753, p > 0.05.
Figure 15 presents the mean number of omissions exhibited during the sessions
where training criteria were met for male and female rats. No statistically-significant
differences were observed strains in male and female rats F(2,38) = 0.035, p > 0.05.
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Figure 13 shows omissions as a function of strain (LE, HZ, or
BRAT) in male rats.
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Figure 14 shows omissions as a function of strain (LE, HZ, or BRAT)
in female rats.
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Figure 15 shows omissions as a function of strain (LE, HZ, or BRAT)
in male and female rats.

50

Bodyweight and water intake

After completing these experiments, all rats were returned to free-feeding and
assessments of bodyweights and amount of 24 hour home-cage water consumption were
conducted.
Figure 16 presents the mean weights of the male rats. Statistically-significant
effects were found in the male rats F(2,26) = 28.3, p < 0.0001, which were due to male
HZ weighing more than LE and BRAT rats, and LE weighing more than BRAT rats. No
statistically significant differences were found between LE and HZ rats.
Figure 17 presents the mean weights of the female rats. Statistically-significant
effects were found in the female rats F(2,25) = 16.07, p < 0.0001, which were due to
female HZ weighing more than LE and BRAT rats, and LE weighing more than BRAT
rats. No statistically significant differences were found between LE and HZ rats.
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Figure 16 shows the mean weights as a function of strain (LE, HZ,
or BRAT) in male rats, ****p < 0.0001 versus LE, *p < 0.05
versus LE.
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Figure 17 shows the mean weights as a function of strain
(LE, HZ, or BRAT) in female rats, **p < 0.01 versus LE,
++++p < 0.0001 versus HZ.

53

Figure 18 presents the 24 hour water consumption in male rats. Statisticallysignificant effects were found in water consumption amounts in male rats F(2,26) = 180,
p < 0.0001, which were due to the BRAT rats drinking more water than LE and HZ rats.
No statistically significant differences were found between LE and HZ rats.
Figure 19 presents the 24 hour water consumption in female rats. Statisticallysignificant effects were found in water consumption amounts in female rats F(2,25) =
295.7, p < 0.0001, which were due to BRAT rats drinking more water than LE and HZ
rats. No statistically significant differences were found between LE and HZ rats.
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Figure 18 shows the 24 hour water consumption as a function of
strain (LE, HZ, or BRAT) in male rats, ****p < 0.0001
versus
LE, ++++p < 0.0001 versus HZ.
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Figure 19 shows the 24 hour water consumption as a function of
strain (LE, HZ, or BRAT) in female rats, ****p < 0.0001 versus
LE, ++++p < 0.0001 versus HZ.
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Figure 20 presents the amount of water male rats consumed during a 60 minute
session. Statistically-significant differences in water consumption were found among the
male rats F(2,26) = 7.862, p < 0.01, which were due to male BRAT rats consuming more
water than LE and HZ. No statistically significant differences were found between LE
and HZ rats.
Figure 21 presents the amount of water female rats consumed during a 60 minute
session. Statistically-significant differences in water consumption were found among the
female rats F(2,25) = 15.73, p < 0.0001, which were due to female BRAT rats consuming
more water than LE and HZ. No statistically significant differences were found between
LE and HZ rats.
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Figure 20 shows the amount of water consumed during a 60
minute session as a function of strain (LE, HZ, or BRAT) in
male rats, **p < 0.01 versus BRAT.
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Figure 21 shows the amount of water consumed during a 60 minute
session as a function of strain (LE, HZ, or BRAT) in female rats, p****
< 0.0001 versus BRAT.
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Figure 22 presents the number of licks made during a 60 minute session in male
rats. Two rats were excluded in this measure due to mechanical error with the lickometer
equipment. Statistically-significant effects were found in the number of licks made in the
male rats F(2,24) = 10.13, p < 0.001, which was due to male BRAT rats exhibiting more
licks than LE and HZ. No statistically significant differences were found between LE and
HZ rats.
Figure 23 presents the number of licks made during a 60 minute session in female
rats. Statistically significant effects were found in the number of licks made in the female
rats F(2,25) = 38.32, p < 0.0001., which was due to female BRAT rats exhibiting more
licks than LE and HZ. No statistically significant differences were found between LE and
HZ rats.
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Figure 22 shows the number of licks made during a 60 minute
session as a function of strain (LE, HZ, or BRAT) in male rats,
**p < 0.01 versus BRAT.
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Figure 23 shows the number of licks made during a 60 minute
session as function of strain (LE, HZ, or BRAT) in female
rats, ****p < 0.0001 versus BRAT.
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DISCUSSION

The present study provides the first report on the assessment of both male and
female BRAT rats using the 5-CSRTT. Male BRAT rats required significantly more
trials to complete this task than LE rats (16.8% higher), while differences were not
observed between strains for the female rats. During the sessions that rats met the
training criteria, only female BRAT rats displayed a lower percent accuracy (51.8%) than
the HZ (61.1%) and LE rats (63.5%). When males and females were combined, the
BRAT rats required significantly more sessions to complete training than both the LE and
HZ rats. Differences also were not found between strains in either male or female rats for
omissions or the number of premature responses. However, when increasing the sample
sizes by combining both male and female rats, a significant increase in premature
responses was observed in the BRAT rats compared to LE and HZ rats. The HZ rats were
found to have heavier free-feeding weights than LE and BRAT rats, while BRAT rats
weighed less than LE and HZ rats—similar to findings reported elsewhere (e.g., Arimura,
Sawano, Redding, & Schally, 1968). VP deficiency led to significantly greater home
cage and experimental water consumption in BRAT rats compared to LE and HZ rats,
while VP deficiency in HZ rats may not have been substantial enough to significantly
enhance water consumption compared to LE rats. Furthermore, the BRAT rats made
significantly more licks during the drinking session than both LE and HZ rats.
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The training criteria used for the present study were developed in order to
determine a steady state for attention accuracy for the purpose of making comparisons
between different strains. These criteria differ from other 5-CSRTT studies, which
usually set training criteria toward attaining some a priori level of accuracy, such as 80%
(e.g., Auclair, Besnard, Newman-Tancredi, & Depoortere, 2009; Agnoli & Carli, 2012).
From the approach used here, many rats, including the LE rats, failed to achieve greater
than 60% choice accuracy, and most were below 80% choice accuracy. Moreover, some
rats were removed from the study due to either failing to pass early phases of training or
to exhibiting too much variability for day to day performance. These criteria suggest that
for studies aiming for a high accuracy, rats may initially reach a steady state of lower
accuracy, such as the 60% value found in the present study, prior to gradually meeting a
higher level of accuracy.
In the present study, differences in attention were found in female BRAT rats but
not in male BRATs. This is the first study to indicate a potential cognitive deficit in
attention in female BRAT rats. Perhaps the present finding of impaired attention accuracy
in the female BRAT rats can be attributed to the effects of hormonal cyclicity; the present
study did not control for the rhythmic release of hormonal factors in the female strains.
Additionally, it has been observed that the BRAT strain exhibits several alterations in a
number of hormonal factors (Sokol and Zimmerman, 1982), and it is thus possible that
these factors may be further disrupted in female versus male BRAT rats. Clearly, more
research is needed to assess how sex differences may interact with VP to account for
potential behavioral or cognitive effects. Moreover, aside from a previous assessment of
pre-pulse inhibition (Feifel, Shilling, & Melendez, 2010) no other behavioral or cognitive
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studies have been conducted between strains in female BRAT rats, and therefore it is
difficult to suggest what type of unique behavioral or cognitive profile may exist for
female rats with VP deficiency.
The closest comparisons between the present findings and previous studies are
those conducted by Jentsch, Arguello, and Anzivino (2003) and Jentsch (2003), which
both used a lateralized reaction time task (see introduction). In the study by Jentsch
(2003), male HZ rats failed to exhibit differences in choice accuracy at 30, 5, and 2.5 sec
durations but displayed improved choice accuracy at a 1 sec duration. In an another
lateralized reaction time study, Jentsch, Arguello, and Anzivino (2003) reported that
BRAT rats showed improved choice accuracy at 2.0 sec duration but displayed impaired
choice accuracy at a 0.2 sec duration (Jenstch, Arguello, & Anzivino, 2003). Considering
these findings together, Jentsch, Arguello, and Anzivino (2003) suggested that increases
in VPergic tone may diminish attention accuracy. However, the present findings fail to
support these conclusions, since accuracy changes were not observed in male BRAT or
HZ rats, and that deficits, rather than improvements, in attention accuracy were observed
in female BRAT rats.
These differences may, in part, owe to the approaches used to assess attention.
The present study employed a 5-CSRTT, which utilizes five receptacles that must be
surveyed by an animal in order to attend to a 0.5 second pulse of light; whereas the
lateralized reaction time task includes only two choices, which are located adjacent to a
central receptacle that an animal uses to begin each trial. Thus, the 5-CSRTT may
provide greater task difficulty, although the differences between these two tasks have yet
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to be empirically studied. Certainly, the present findings are more in line with previous
investigations (see below) suggesting that VP deficiency impairs cognitive performance.
As mentioned previously, the BRAT rats made significantly more premature
responses than the LE and HZ rats. In the 5-CSRTT premature responding is generally
considered a measure of impulsivity (e.g., Robbins, 2002; Chudasama & Robbins, 2004;
Amitai & Markou, 2010). For example, psychostimulants such as methylphenidate tend
to dose-dependently increase premature responding (e.g. Paterson, Ricciardi, Wetzler, &
Hanania, 2011; Navarra, et al. 2008), which may relate to enhanced locomotor activity at
similar doses. Given this general interpretation for premature responding in the 5CSRTT, the present findings may indicate greater impulsivity in BRAT rats. BRAT rats
have also been shown to exhibit increased locomotor activity compared to LE controls
(e.g.,Cilia, et al. 2010; Schank, 2009) and have lower increases in locomotor activity
following d-amphetamine administration than LE controls (Cilia et al., 2010). The
increases in impulsivity found in the present study and increased locomotor activity
found in other studies might be caused by differences in the dopamine system of BRAT
rats (e.g., see Dawson Jr., Wallace, & King, 1990; Feenstra, Snijdewint, Galen, & Boer,
1990; and Shilling et al., 2006, for altered neurotransmitter levels found in BRATs). In
particular, Shilling et al. (2006) reported that BRAT rats displayed an upregulation of
dopamine D2 receptors in the nucleus accumbens shell and dorsomedial caudate/putamen
compared to LE rats.
As noted above, the 5-CSRTT has been suggested to involve various subtypes of
attention— such as selective and divided attention— in order to perform the task (e.g.,
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Robbins, 2002). Much progress has been made delineating the substrates and functional
neurochemistry between these subtypes of attention. For example, a study by McGaughy,
Kaiser, and Sarter (1998) demonstrated a direct relationship of reduced
acheylcholinesterase-fiber density and disrupted performance in a rat model of sustained
attention— suggesting that cholinergic transmission is necessary for this particular
subtype of attention. Moreover, perhaps one of the more intuitive mechanisms to occur
before attention processes can begin is arousal. Among the many brain structures
involved in arousal, the brain stem is particularly important for initiating this process
(e.g., see Jones, 2003). As such, two substructures of the brain stem, the medulla and
locus coeruleus, have been largely implicated in arousal and have been shown to involve
neurotransmitters such as glutamate and noradrenaline (e.g., Jones, 2003; Sara, 2009).
The BRAT strain has been shown to have developmental impairments within the medulla
measured in neonatal BRAT rat pups (Boer, Van Rheenen-Verberg, & Uylings, 1982),
and elevations in noradrenergic concentrations were also found in the strain (Dawson Jr.,
Wallace, & King, 1990). Although further research is necessary to evaluate these agents
within the process of arousal, and particularly across sexes within the BRAT strain, we
the investigators suspect that perturbations within these arousal mechanisms may also be
related to the lower accuracy effect found in the present study.
Few other studies have evaluated cognitive differences in the BRAT strain—
several of which have been briefly presented in the introduction of this document. As
previously mentioned in the introduction of this document, impaired performance in
shock-motivated memory paradigms have been suggested in the BRAT strain of rats (De
Wied, Bohus, & Van Wimersma Greidanus, 1975; Stoehr, Cheng, & North, 1993).
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BRAT rats also display an innate deficit in the pre-pulse inhibition response, which
appears to measure sensory gating; a process implicated in early attention processing
(e.g., Braff, Swerdlow, & Geyer, 1999). Moreover, current research has directly linked
polymorphisms within the AVPR1a promoter region of the VP gene to altered pre-pulse
inhibition responses (Levin et al., 2009). This involvement of VP in pre-pulse measures
may be partially responsible for the pre-pulse inhibition deficits found in both male (e.g.,
Feifel & Priebe, 2001; Cilia et al., 2010; Feifel, Melendez, & Shilling, 2004) and female
(Feifel, Shilling, & Melendez, 2010) BRATs; though, more research is necessary
exploring this area. Nonetheless, such deficits in pre-pulse inhibition may compromise
performance of BRATs in attention procedures, possibly resulting in a poorer ability to
shift attention between stimuli. The findings, taken with those from the present study,
suggest that diminished VP concentrations contribute to declines in attention, and
potentially other domains of cognition.
In addition to exploring the role vasopressin may play in behavioral and cognitive
processes, VP deficiency has been recently explored as a screening model for
antipsychotic drugs. Both antipsychotic drugs (e.g., Cilia et al., 2010; Feifel & Priebe,
2001) and the putative antipsychotic drug and neurotensin NT1 receptor agonist
PD149163 (Feifel, Melendez, & Shilling, 2004) have been shown to attenuate pre-pulse
inhibition deficits in BRAT rats. Further, PD149163 and the antipsychotic drug
clozapine have both reversed social discrimination deficits displayed in BRAT rats
(Feifel et al., 2009). In addition to these behavioral data, subchronic administration of the
NMDA noncompetitive receptor antagonist and psychotomimetic phencyclidine has been
shown to reduce vasopressin V1a receptor binding in the brain, which corresponds with
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deficits in social interaction (Tanaka et al., 2003). Further, as noted earlier, Shilling et al.
(2006) reported an upregulation of D2 receptors, possibly suggestive of enhanced
dopaminergic signaling. Taken together, BRAT rats may have utility for antipsychotic
drug development.
Taking together these pre-pulse inhibition findings and social deficits observed in
the BRAT strain, researchers have suggested that the strain may be a useful animal model
of schizophrenia due to the behavioral responses following both established and novel
antipsychotic drug administration (e.g., Feifel, 2010; Cilia et al., 2010; Feifel et al.,
2009). Other research has also included VP as a potential biochemical candidate involved
in austism spectrum disorder (e.g., see Carter, 2007; and, Lukas & Neumann, 2012 for
review on the subject). As such, the BRATs have also been suggested to perhaps
subserve a role in this area of research (e.g., Insel, O’Brien, & Leckman, 1999; Schank,
2009); however, further investigation is necessary which expands upon this possibility.
The present study adds to previous research investigating the behavioral-cognitive
profile of the BRAT rat, indicating that VP deficiency may diminish attention in female,
but perhaps not male, BRAT rats. More research is necessary which further evaluates the
other perturbed factors in the BRAT strain (e.g., hormones, monoamines, etc.), and
moreover, how these alterations can affect performance in behavioral and cognitive tasks.
Additionally, the present findings and earlier investigations suggest that BRAT rats could
be used for the screening of antipsychotic drugs; particularly in models sensitive to
impairments in sociality or cognitive functioning. Further studies are needed to evaluate
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the behavioral and cognitive profile of VP deficiency and to elucidate the
neurodevelopmental impact of VP deficiency.
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APPENDIX A
Five-Choice Serial Reaction Time Task Experimental Chamber
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APPENDIX B
Box Diagram for Final Phase of 5-CSRTT Training

T=5sec

LP

CR? YES
Choice Lights
OFF
Houselight ON
Food Hopper ON

5sec

Choice Light ON

Choice Lights OFF

Choice Lights OFF

NP

Houselight ON

(0.10sec)

Houselight ON

Houselight ON

NP

5.0s LH

ICR/NNP

Choice Lights OFF
Houselight ON
L DEAC (5.0s)
LEGEND
LP = Lever Press
NP = Nose Poke
T = Time Interval
LH = Limited Hold Period
CR = Correct Response
ICR = Incorrect Response
NNP = No Nose Poke
L DEAC = Lever Deactivated
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APPENDIX C
IACUC Protocol Approval
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APPENDIX D
Habituation Session Programming

\Test 5csrtt
\FT60
^HOUSELIGHT = 15
^POKE1 = 4
^POKE2 = 5
^POKE3 = 6
^POKE4 = 7
^POKE5 = 8
^FAN = 16
^PELLET = 9
S.S.1,
S1,
1":ON ^FAN--->S2
S2,
#START: ON ^HOUSELIGHT, ^POKE1, ^POKE2, ^POKE3, ^POKE4, ^POKE5--->S3
S3,
#R^POKE1:ADD A; OFF ^POKE1, ^POKE2, ^POKE3, ^POKE4, ^POKE5; ON ^PELLET; SHOW 1,
POKE1, A--->S4
#R^POKE2:ADD B; OFF ^POKE1, ^POKE2, ^POKE3, ^POKE4, ^POKE5; ON ^PELLET; SHOW 2,
POKE2, B--->S4
#R^POKE3:ADD C; OFF ^POKE1, ^POKE2, ^POKE3, ^POKE4, ^POKE5; ON ^PELLET; SHOW 3,
POKE3, C--->S4
#R^POKE4:ADD D; OFF ^POKE1, ^POKE2, ^POKE3, ^POKE4, ^POKE5; ON ^PELLET; SHOW 4,
POKE4, D--->S4
#R^POKE5:ADD E; OFF ^POKE1, ^POKE2, ^POKE3, ^POKE4, ^POKE5; ON ^PELLET; SHOW 5,
POKE5, E--->S4
S4,
0.1":OFF ^PELLET; ADD F;SHOW 6, PELLET, F--->S5
S5,
5":ON ^POKE1, ^POKE2, ^POKE3, ^POKE4, ^POKE5--->S3
S.S.2,
S1,
#START:--->S2
S2,
60":ON ^PELLET;ADD F;SHOW 6, PELLET, F--->S3
S3,
0.1":OFF ^PELLET--->S2
S.S.3,
S1,
45':--->STOPABORTFLUSH
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APPENDIX E
Phase 1 Training Programming

\Test 5csrtt
\FT60
^HOUSELIGHT = 15
^POKE1 = 4
^POKE2 = 5
^POKE3 = 6
^POKE4 = 7
^POKE5 = 8
^FAN = 16
^PELLET = 9

S.S.1,
S1,
1":ON ^FAN--->S2
S2,
#START: ON ^HOUSELIGHT, ^POKE1, ^POKE2, ^POKE3, ^POKE4, ^POKE5--->S3
S3,
#R^POKE1:ADD A; OFF ^POKE1, ^POKE2, ^POKE3, ^POKE4, ^POKE5; ON ^PELLET; SHOW 1,
POKE1, A--->S4
#R^POKE2:ADD B; OFF ^POKE1, ^POKE2, ^POKE3, ^POKE4, ^POKE5; ON ^PELLET; SHOW 2,
POKE2, B--->S4
#R^POKE3:ADD C; OFF ^POKE1, ^POKE2, ^POKE3, ^POKE4, ^POKE5; ON ^PELLET; SHOW 3,
POKE3, C--->S4
#R^POKE4:ADD D; OFF ^POKE1, ^POKE2, ^POKE3, ^POKE4, ^POKE5; ON ^PELLET; SHOW 4,
POKE4, D--->S4
#R^POKE5:ADD E; OFF ^POKE1, ^POKE2, ^POKE3, ^POKE4, ^POKE5; ON ^PELLET; SHOW 5,
POKE5, E--->S4
S4,
0.1":OFF ^PELLET; ADD F;SHOW 6, PELLET, F--->S5
S5,
5":ON ^POKE1, ^POKE2, ^POKE3, ^POKE4, ^POKE5--->S3
S.S.2,
S1,
30':--->STOPABORTFLUSH
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APPENDIX F
Phase 2 of Training Programming

\Test 5csrtt
\FT60
^HOUSELIGHT = 15
^POKE1 = 4
^POKE2 = 5
^POKE3 = 6
^POKE4 = 7
^POKE5 = 8
^FAN = 16
^PELLET = 9
^CENTERLEVER = 2

S.S.1,
S1,
1":ON ^FAN--->S2
S2,
#START: ON ^HOUSELIGHT,^CENTERLEVER--->S3
S3,
#R^CENTERLEVER:ON ^POKE1, ^POKE2, ^POKE3, ^POKE4, ^POKE5--->S4
S4,
#R^POKE1:ADD A; OFF ^POKE1, ^POKE2, ^POKE3, ^POKE4, ^POKE5; ON ^PELLET;
SHOW 1, POKE1, A--->S5
#R^POKE2:ADD B; OFF ^POKE1, ^POKE2, ^POKE3, ^POKE4, ^POKE5; ON ^PELLET;
SHOW 2, POKE2, B--->S5
#R^POKE3:ADD C; OFF ^POKE1, ^POKE2, ^POKE3, ^POKE4, ^POKE5; ON ^PELLET;
SHOW 3, POKE3, C--->S5
#R^POKE4:ADD D; OFF ^POKE1, ^POKE2, ^POKE3, ^POKE4, ^POKE5; ON ^PELLET;
SHOW 4, POKE4, D--->S5
#R^POKE5:ADD E; OFF ^POKE1, ^POKE2, ^POKE3, ^POKE4, ^POKE5; ON ^PELLET;
SHOW 5, POKE5, E--->S5
S5,
0.1":OFF ^PELLET; ADD F;SHOW 6, PELLET, F--->S3

S.S.2,
S1,
30':--->STOPABORTFLUSH
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APPENDIX G
Phase 3 of Training Programming

\Five choice serial reaction time task
\Written by Adam Prus and Mike Berquist
\January 18 2012
\0.5 sec light pulse in recepticle. Nosepoke leads to food pellet.
\Session last 80 trials or 30 minutes
\incorrect or omission leads to 5 sec time out
\ Training steps = 1. FT60 2. Nosepoke = food pellet delivery (all receptacles lighted) 3. Only
light hole triggers pellet (stays lit until response - incorrect leads to timeout)
\4. Lever press triggers light (light stays on) 5. Lever press triggers light (light stays on for
maybe 5 sec 6. Same but reduce light duration until 0.5" responding occurs
\STEP 2. Training Here

\Alias

^Poke1 = 4
^Poke2 = 5
^Poke3 = 6
^Poke4 = 7
^Poke5 = 8
^Houselight = 15
^CenterLever = 2
^Pellet = 9
^Fan = 16

\A=PREMATURE RESPONSE
\B=CORRECT RESPONSE
\C=OMISSIONS
\D=TRIAL
\E=CORRECT RESPONSE
\F=INCORRECT RESPONSE
\G=TOTAL RESPONSES
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\H=FOR NO RESPONSE CALCULATION
\Y=CHOOSES LIGHT
\Z=LIST FOR RANDOM LIGHT
LIST Z = 4,5,6,7,8
DIM B = 6

\SHOW 1 = TIME
\SHOW 2 = NUMBER OF TRIALS
\SHOW 3 = OMISSIONS
\SHOW 4 = PREMATURE
\SHOW 5 =
\SHOW 6 = %CORRECT
\SHOW 7 = TOTAL RESPONSES
\-------------------------------------------------------------------------------S.S.1,
S1,
1": ON ^FAN--->S2
S2,
#START: ON ^HOUSELIGHT,^CENTERLEVER--->S3
S3,
#R2:ADD D--->S4
S4,
0.1":RANDI Y = Z; SET B(1)=Y;SHOW 2, TRIALS, D; IF B(1)=4 [@FOUR,@OTHER]
@FOUR:SET B(2)=5, B(3)=6, B(4)=7, B(5)=8--->S5
@OTHER:IF B(1)=5 [@FIVE,@OTHER]
@FIVE:SET B(2)=4,B(3)=6,B(4)=7,B(5)=8--->S5
@OTHER:IF B(1)=6 [@SIX,@OTHER]
@SIX:SET B(2)=4,B(3)=5,B(4)=7,B(5)=8--->S5
@OTHER:IF B(1)=7 [@SEVEN,@EIGHT]
@SEVEN:SET B(2)=4,B(3)=5,B(4)=6,B(5)=8--->S5
@EIGHT:SET B(2)=4,B(3)=5,B(4)=6,B(5)=7--->S5
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S5,
5":ON Y--->S6 \PREMATURE RESPONSE GOES HERE
S6,
#RB(1):ADD E;ON ^PELLET;OFF Y;SHOW 6,CORRECT,E--->S7 \SET G=E+F;SHOW 6,
%CORRECT, (E/G*100);SHOW 7,TOT_RESP,G
#RB(2)!#RB(3)!#RB(4)!#RB(5):OFF Y; ADD F--->S8 \INCORRECT,TIMEOUT ;SET
G=E+FSHOW 6, %CORRECT, (E/G*100);SHOW 7,TOT_RESP,G
5":OFF Y;ADD C;SHOW 3, OMISSIONS, C--->S8
S7,
0.1":OFF ^PELLET--->S3
S8, \TIMEOUT1
0.1":OFF ^HOUSELIGHT--->S9
S9, \TIMEOUT2
5":ON ^HOUSELIGHT--->S3

\--------------------------------------------------------------------------------S.S.2,
S1,
#START:--->S2
S2,
1":ADD T;Show 1, Timer, T; IF D>100 [@END,@CONT]
@END:SET D=100;IF G=0 [@NORESPONSE,@RESPONSE]
@NORESPONSE:SET H = 999;SHOW 1, TIMER, T; SHOW 2, TRIALS, D;
SHOW 3, OMISSIONS, C;SHOW 4, PREMATURE, A; SHOW 6, CORRECT, E;SHOW
7,TOT_RESP,G--->STOPABORTFLUSH
@RESPONSE:SHOW 1, TIMEr, T; SHOW 2, TRIALS, D; SHOW 3, OMISSIONS,
C;SHOW 4, PREMATURE, A; SHOW 6, CORRECT, e--->STOPABORTFLUSH
@CONT: IF T>=1800 [@END,@CONT]
@END:SHOW 1, TIMER, T; SHOW 2, TRIALS, D; SHOW 3, OMISSIONS,
C;SHOW 4, PREMATURE, A; SHOW 6, CORRECT, e--->STOPABORTFLUSH
@CONT:--->S2
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APPENDIX H
Phase 4 of Training Programming

\Five choice serial reaction time task
\Written by Adam Prus and Mike Berquist
\January 18 2012
\0.5 sec light pulse in recepticle. Nosepoke leads to food pellet.
\Session last 80 trials or 30 minutes
\incorrect or omission leads to 5 sec time out
\ Training steps = 1. FT60 2. Nosepoke = food pellet delivery (all receptacles lighted) 3. Only
light hole triggers pellet (stays lit until response - incorrect leads to timeout)
\4. Lever press triggers light (light stays on) 5. Lever press triggers light (light stays on for
maybe 5 sec 6. Same but reduce light duration until 0.5" responding occurs
\STEP 2. Training Here

\Alias

^Poke1 = 4
^Poke2 = 5
^Poke3 = 6
^Poke4 = 7
^Poke5 = 8
^Houselight = 15
^CenterLever = 2
^Pellet = 9
^Fan = 16

\A=PREMATURE RESPONSE
\B=CORRECT RESPONSE
\C=OMISSIONS
\D=TRIAL
\E=CORRECT RESPONSE
\F=INCORRECT RESPONSE
\G=TOTAL RESPONSES
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\H=FOR NO RESPONSE CALCULATION
\Y=CHOOSES LIGHT
\Z=LIST FOR RANDOM LIGHT
LIST Z = 4,5,6,7,8
DIM B = 6

\SHOW 1 = TIME
\SHOW 2 = NUMBER OF TRIALS
\SHOW 3 = OMISSIONS
\SHOW 4 = PREMATURE
\SHOW 5 =
\SHOW 6 = %CORRECT
\SHOW 7 = TOTAL RESPONSES
\-------------------------------------------------------------------------------S.S.1,
S1,
1": ON ^FAN--->S2
S2,
#START: ON ^HOUSELIGHT,^CENTERLEVER--->S3
S3,
#R2:ADD D--->S4
S4,
0.1":RANDI Y = Z; SET B(1)=Y;SHOW 2, TRIALS, D; IF B(1)=4 [@FOUR,@OTHER]
@FOUR:SET B(2)=5, B(3)=6, B(4)=7, B(5)=8--->S5
@OTHER:IF B(1)=5 [@FIVE,@OTHER]
@FIVE:SET B(2)=4,B(3)=6,B(4)=7,B(5)=8--->S5
@OTHER:IF B(1)=6 [@SIX,@OTHER]
@SIX:SET B(2)=4,B(3)=5,B(4)=7,B(5)=8--->S5
@OTHER:IF B(1)=7 [@SEVEN,@EIGHT]
@SEVEN:SET B(2)=4,B(3)=5,B(4)=6,B(5)=8--->S5
@EIGHT:SET B(2)=4,B(3)=5,B(4)=6,B(5)=7--->S5
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S5,
5":ON Y--->S6 \PREMATURE RESPONSE GOES HERE
#RB(1)!#RB(2)!#RB(3)!#RB(4)!#RB(5):ADD A;SHOW 4, PREMATURE, A--->S8
S6,
#RB(1):ADD E;ON ^PELLET;OFF Y;SHOW 6,CORRECT,E--->S7 \SET G=E+F;SHOW 6,
CORRECT, E;SHOW 7,TOT_RESP,G
#RB(2)!#RB(3)!#RB(4)!#RB(5):OFF Y; ADD F--->S8 \INCORRECT,TIMEOUT ;SET
G=E+F;SHOW 6, CORRECT, E;SHOW 7,TOT_RESP,G
5":OFF Y;ADD C;SHOW 3, OMISSIONS, C--->S8
S7,
0.1":OFF ^PELLET--->S3
S8, \TIMEOUT1
0.1":OFF ^HOUSELIGHT--->S9
S9, \TIMEOUT2
5":ON ^HOUSELIGHT--->S3

\--------------------------------------------------------------------------------S.S.2,
S1,
#START:--->S2
S2,
1":ADD T;Show 1, Timer, T; IF D>100 [@END,@CONT]
@END:SET D=100;IF G=0 [@NORESPONSE,@RESPONSE]
@NORESPONSE:SET H = 999;SHOW 1, TIMER, T; SHOW 2, TRIALS, D;
SHOW 3, OMISSIONS, C;SHOW 4, PREMATURE, A; SHOW 6, CORRECT, E;SHOW
7,TOT_RESP,G--->STOPABORTFLUSH
@RESPONSE:SHOW 1, TIMEr, T; SHOW 2, TRIALS, D; SHOW 3, OMISSIONS,
C;SHOW 4, PREMATURE, A; SHOW 6, CORRECT, E--->STOPABORTFLUSH
@CONT: IF T>=1800 [@END,@CONT]
@END:SHOW 1, TIMER, T; SHOW 2, TRIALS, D; SHOW 3, OMISSIONS,
C;SHOW 4, PREMATURE, A; SHOW 6, CORRECT, E--->STOPABORTFLUSH
@CONT:--->S2
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APPENDIX I
Phase 5_Final Phase of 5-CSRTT Training Programming

\Five choice serial reaction time task
\Written by Adam Prus and Mike Berquist
\April 4 2012
\0.5 sec light pulse in recepticle. Nosepoke leads to food pellet.
\Session last 80 trials or 30 minutes
\incorrect or omission leads to 5 sec time out
\ Training steps = 1. FT60 2. Nosepoke = food pellet delivery (all receptacles lighted) 3. Only
light hole triggers pellet (stays lit until response - incorrect leads to timeout)
\4. Lever press triggers light (light stays on) 5. Lever press triggers light (light stays on for
maybe 5 sec 6. Same but reduce light duration until 0.5" responding occurs
\STEP 2. Training Here

\Alias

^Poke1 = 4
^Poke2 = 5
^Poke3 = 6
^Poke4 = 7
^Poke5 = 8
^Houselight = 15
^CenterLever = 2
^Pellet = 9
^Fan = 16

\A=PREMATURE RESPONSE
\B=CORRECT RESPONSE
\C=OMISSIONS
\D=TRIAL
\E=CORRECT RESPONSE
\F=INCORRECT RESPONSE
\G=TOTAL RESPONSES
\H=FOR NO RESPONSE CALCULATION
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\I=SIGNAL
\J=OMISSION
\K=RESPONSE
\L=open?
\M=OPEN?
\N=OPEN?
\Y=CHOOSES LIGHT
\Z=LIST FOR RANDOM LIGHT
\Z PULSES
\Z1=START SS3
\Z2=OMISSION
LIST Z = 4,5,6,7,8
DIM B = 6
DIM I = 100
DIM J = 100
DIM K = 100
DIM L = 100
DIM M = 100
DIM N = 100

\SHOW 1 = TIME
\SHOW 2 = NUMBER OF TRIALS
\SHOW 3 = OMISSIONS
\SHOW 4 = PREMATURE
\SHOW 5 = INCORRECT
\SHOW 6 = CORRECT
\SHOW 7 = TOTAL RESPONSES
\-------------------------------------------------------------------------------S.S.1,
S1,
1": ON ^FAN--->S2
S2,
#START: ON ^HOUSELIGHT,^CENTERLEVER;SET D=0--->S3
S3,
#R2:ADD D--->S4
S4,
0.1":RANDI Y = Z; SET B(1)=Y;SHOW 2, TRIALS, D;Z1; IF B(1)=4 [@FOUR,@OTHER]
@FOUR:SET B(2)=5, B(3)=6, B(4)=7, B(5)=8, L(D)=1--->S5 \tag
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@OTHER:IF B(1)=5 [@FIVE,@OTHER]
@FIVE:SET B(2)=4,B(3)=6,B(4)=7,B(5)=8, L(D)=2--->S5 \tag
@OTHER:IF B(1)=6 [@SIX,@OTHER]
@SIX:SET B(2)=4,B(3)=5,B(4)=7,B(5)=8, L(D)=3--->S5 \tag
@OTHER:IF B(1)=7 [@SEVEN,@EIGHT]
@SEVEN:SET B(2)=4,B(3)=5,B(4)=6,B(5)=8, L(D)=4--->S5 \tag
@EIGHT:SET B(2)=4,B(3)=5,B(4)=6,B(5)=7, L(D)=5--->S5 \tag
S5,
5":ON Y--->S6 \PREMATURE RESPONSE GOES HERE
#RB(1)!#RB(2)!#RB(3)!#RB(4)!#RB(5):ADD A;SHOW 4, PREMATURE, A--->S9
S6,
#RB(1):ADD E;ON ^PELLET;OFF Y;SHOW 6,CORRECT,E;Z2--->S8 \SET G=E+F;SHOW
6, CORRECT, E;SHOW 7,TOT_RESP,G
#RB(2)!#RB(3)!#RB(4)!#RB(5):OFF Y; ADD F;SHOW 5,INCORRECT,F;Z2--->S9
\INCORRECT,TIMEOUT ;SET G=E+F;SHOW 6, CORRECT, E;SHOW 7,TOT_RESP,G
0.5":OFF Y;Z2--->S7
S7,
#RB(1):ADD E;ON ^PELLET;OFF Y;SHOW 6,CORRECT,E--->S8 \SET G=E+F;SHOW 6,
CORRECT, E;SHOW 7,TOT_RESP,G
#RB(2)!#RB(3)!#RB(4)!#RB(5):OFF Y; ADD F;SHOW 5,INCORRECT,F--->S9
\INCORRECT,TIMEOUT ;SET G=E+F;SHOW 6, CORRECT, E;SHOW 7,TOT_RESP,G
5":OFF Y;ADD C;SHOW 3, OMISSIONS, C--->S9
S8,
0.1":OFF ^PELLET;Z3--->S3
S9, \TIMEOUT1
0.1":OFF ^HOUSELIGHT;Z3--->S10
S10, \TIMEOUT2
5":ON ^HOUSELIGHT--->S3

\--------------------------------------------------------------------------------S.S.2, \ENDS AFTER 30 MIN OR 100 TRIALS
S1,
#START:--->S2
S2,
1":ADD T;Show 1, Timer, T; IF D>100 [@END,@CONT]
@END:SET D=100;IF G=0 [@NORESPONSE,@RESPONSE]
@NORESPONSE:SET H = 999;SHOW 1, TIMER, T; SHOW 2, TRIALS, D;
SHOW 3, OMISSIONS, C;SHOW 4, PREMATURE, A;SHOW 5, INCORRECT, F;SHOW 6,
CORRECT, E;SHOW 7,TOT_RESP,G--->STOPABORTFLUSH
@RESPONSE:SHOW 1, TIMER, T; SHOW 2, TRIALS, D; SHOW 3, OMISSIONS,
C;SHOW 4, PREMATURE, A;SHOW 5,INCORRECT,F; SHOW 6, CORRECT, E-->STOPABORTFLUSH
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@CONT: IF T>=1800 [@END,@CONT]
@END:SHOW 1, TIMER, T; SHOW 2, TRIALS, D; SHOW 3, OMISSIONS,
C;SHOW 4, PREMATURE, A; SHOW 6, CORRECT, E--->STOPABORTFLUSH
@CONT:--->S2
\----------------------------------------------------------------------------------S.S.3, \DV PER TRIAL
S1,
#Z1:SET I(D)=Y--->S2 \SIGNAL POSITION
S2,
#Z2:SET J(D)=1--->S3 \ONLY GATHERS PREMATURES
#R4:SET K(D)=4--->S1
#R5:SET K(D)=5--->S1
#R6:SET K(D)=6--->S1
#R7:SET K(D)=7--->S1
#R8:SET K(D)=8--->S1
S3,
#Z3:SET M(D)=1--->S1 \ONLY GATHERS RESPONSES AFTER SIGNAL
#R4:SET N(D)=4--->S1
#R5:SET N(D)=5--->S1
#R6:SET N(D)=6--->S1
#R7:SET N(D)=7--->S1
#R8:SET N(D)=8--->S1
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